In addition, although many drugs targeting oncogenic kinases have been used for the treatment of cancers, only a few drugs targeting PTPs (e.g., PTP1B, SHP2, CDC25, and PRLs) are under clinical trials [204]. The gene discussed is CDC25C; the disease is cancer.